Capricorn Fund Managers’s Takeda Pharmaceutical TAK Stock Holding History

Capricorn Fund Managers’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$191K	Buy	+10,517	New	+$186K	0.02%	133
2023 Q4	–	Sell	-204,892	Closed	-$3.17M	–	85
2023 Q3	$3.17M	Sell	204,892 -663,525	-76%	-$10.3M	1.1%	24
2023 Q2	$13.6M	Buy	+868,417	New	+$14.2M	4.9%	6
2022 Q4	–	Sell	-277,783	Closed	-$3.6M	–	103
2022 Q3	$3.6M	Buy	+277,783	New	+$3.86M	1.13%	23
2022 Q1	–	Sell	-1,568,306	Closed	-$21.4M	–	115
2021 Q4	$21.4M	Buy	+1,568,306	New	+$22M	6.01%	4

Other funds holding TAK

Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return

Ethic Inc New York $8.7B AUM 37.39% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Hantz Financial Services Southfield, Michigan $7.48B AUM 14.09% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Capricorn Fund Managers's TAK Position: Q3 2026 in Review

Capricorn Fund Managers opened a new position in Takeda Pharmaceutical (TAK) in Q3 2026: 10,517 shares worth $191K. The stake represents 0.02% of the portfolio and ranks #133 among its holdings. This is a return to the name: Capricorn Fund Managers previously reported a position in TAK as recently as Q3 2023.

Capricorn Fund Managers first reported a position in TAK in Q4 2021 and has held it in 5 quarters since. The position peaked at $21.4M in Q4 2021. 214 funds tracked by Wall St. Rank hold TAK as of Q3 2026.

Capricorn Fund Managers held 10,517 shares of Takeda Pharmaceutical worth $191K as of Q3 2026.
Takeda Pharmaceutical was a new Capricorn Fund Managers position in Q3 2026.
Takeda Pharmaceutical made up 0.02% of Capricorn Fund Managers's portfolio in Q3 2026, its #133 holding.
Capricorn Fund Managers first reported a position in Takeda Pharmaceutical in Q4 2021 and has held it in 5 quarters since.
Capricorn Fund Managers's Takeda Pharmaceutical position peaked at $21.4M in Q4 2021.
214 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.

Based on Capricorn Fund Managers's 13F filing for Q3 2026, filed 3 Nov 2026.